v3 Template
H

HYTN Innovations Inc.

Pharmaceuticals and Cannabis ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$1.5M
Funding Rounds
2
Last Funding
2024-02-09

About HYTN Innovations Inc.

HYTN Innovations Inc. is dedicated to revolutionizing the delivery of natural medicines to patients worldwide through elevated GMP manufacturing of pharma-quality psychoactive and psychotropic compounds. Their purpose-built facility balances innovation, scalability, and cost-efficiency, ensuring high-quality production for global market access in non-sterile pharmaceuticals.

Products & Services

GMP Cannabis Processing:Processing cannabis products to meet the highest GMP standards, including final packaged goods in jars and bags, bulk packaging, solventless extract manufacture, and cannabis vape manufacturing.
GMP Psilocybin Mushroom Manufacturing:Cultivating, processing, and releasing psilocybin mushrooms under GMP certification, offering final packaged goods in sachets and bulk packaging.
GMP Active Pharmaceutical Ingredient (API) Fabrication:Fabricating high-quality APIs for clinical applications, including live resin API, bulk dry flower API, bulk dry psilocybin mushroom API, and bulk solventless extraction API.
Cannabis Consumer Packaged Goods:Creating high-quality consumer cannabis products such as nano emulsions, beverages, edibles, dry flower processing, and non-solid extracts.
Elevation Technology:Proprietary technology creating clear, odorless emulsions with nano-sized droplets for increased absorption and bioavailability, ensuring consistent effects and stable formulations for pharmaceutical applications.

Specialties

GMP Manufacturing Psychoactive and Psychotropic Compounds Cannabis Processing Psilocybin Mushroom Manufacturing Active Pharmaceutical Ingredient (API) Fabrication Nano Emulsion Technology Cannabinoid-based Pharmaceutical Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 1000000
MR: -
FA: up to C$1,000,000
FAN: 1000000
D: 2024-02-09
FD: 2024-02-09
-
2 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 505000
MR: -
FA: $505,000
FAN: 505000
D: 2023-10-26
FD: 2023-10-26
1 investors
Non-brokered Private Placement Latest
2024-02-09
$1.0M
Non-brokered Private Placement 2023-10-26
$505K

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Elliot McKerr

CEO

J

Jason Broome

COO

P

Paul More

CFO

R

Rick Barr

Strategic Advisor

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

HYTN Innovations Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
hytn.ca
Industries
Pharmaceuticals and Cannabis
Company Size
~40 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro